[1]
|
Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O., et al. (2010) 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League against Rheumatism Collaborative Initiative. Arthritis & Rheumatology, 62, 2569-2581. https://doi.org/10.1002/art.27584
|
[2]
|
Beighton, P., Solomon, L. and Valkenburg, H.A. (1975) Rheumatoid Arthritis in a Rural South African Negro Population. Annals of Rheumatic Diseases, 34, 136-141. https://doi.org/10.1136/ard.34.2.136
|
[3]
|
Halabi, H., Alarfaj, A., Alawneh, K., Alballa, S., Alsaeid, K., Badsha, H., et al. (2015) Challenges and Opportunities in the Early Diagnosis and Optimal Management of Rheumatoid Arthritis in Africa and the Middle East. International Journal of Rheumatic Diseases, 18, 268-275. https://doi.org/10.1111/1756-185X.12320
|
[4]
|
Finckh, A., Gilbert, B., Hodkinson, B., Bae, S.C., Thomas, R., Deane, K.D., et al. (2022) Global Epidemiology of Rheumatoid Arthritis. Nature Reviews Rheumatology, 18, 591-602. https://doi.org/10.1038/s41584-022-00827-y
|
[5]
|
Alamanos, Y. and Drosos, A.A. (2005) Epidemiology of Adult Rheumatoid Arthritis. Autoimmunity Reviews, 4, 130-136. https://doi.org/10.1016/j.autrev.2004.09.002
|
[6]
|
Gabriel, S.E. (2001) The Epidemiology of Rheumatoid Arthritis. Rheumatic Disease Clinics of North America, 27, 269-281. https://doi.org/10.1016/S0889-857X(05)70201-5
|
[7]
|
Mijiyawa, M. (1996) Rheumatoid Arthritis in Black Africa. La Revue de Médecine Interne, 17, 625-626. https://doi.org/10.1016/0248-8663(96)87147-5
|
[8]
|
Scott, D.L., Wolfe, F. and Huizinga, T.W. (2010) Rheumatoid Arthritis. The Lancet, 25, 1094-1108. https://doi.org/10.1016/S0140-6736(10)60826-4
|
[9]
|
Charles, J., Britt, H. and Pan, Y. (2013) Rheumatoid Arthritis. Australian Family Physician, 42, 765.
|
[10]
|
Symmons, D., Turner, G., Webb, R., Asten, P., Barrett, E., Lunt, M., et al. (2002) The Prevalence of Rheumatoid Arthritis in the United Kingdom: New Estimates for a New Century. Rheumatology (Oxford), 41, 793-800. https://doi.org/10.1093/rheumatology/41.7.793
|
[11]
|
Alamanos, Y., Voulgari, P.V. and Drosos, A.A. (2006) Incidence and Prevalence of Rheumatoid Arthritis, Based on the 1987 American College of Rheumatology Criteria: A Systematic Review. Seminars in Arthritis and Rheumatism, 36, 182-188. https://doi.org/10.1016/j.semarthrit.2006.08.006
|
[12]
|
Dowman, B., Campbell, R.M., Zgaga, L., Adeloye, D. and Chan, K.Y. (2013) Estimating the Burden of Rheumatoid Arthritis in Africa: A Systematic Analysis. Journal of Global Health, 2, Article ID: 020406. https://doi.org/10.7189/jogh.02.020406
|
[13]
|
Anaya, J.M., Correa, P.A., Mantilla, R.D., Jimenez, F., Kuffner, T. and McNicholl, J.M. (2001) Rheumatoid Arthritis in African Colombians from Quibdo. Seminars in Arthritis and Rheumatism, 31, 191-198. https://doi.org/10.1053/sarh.2001.27737
|
[14]
|
Greenwood, B.M. (1969) Polyarthritis in Western Nigeria. I. Rheumatoid Arthritis. Annals of Rheumatic Diseases, 28, 488-496. https://doi.org/10.1136/ard.28.5.488
|
[15]
|
Kalla, A.A. and Tikly, M. (2003) Rheumatoid Arthritis in the Developing World. Best Practice & Research: Clinical Rheumatology, 17, 863-875. https://doi.org/10.1016/S1521-6942(03)00047-0
|
[16]
|
Malemba, J.J. and Mbuyi-Muamba, J.M. (2008) Clinical and Epidemiological Features of Rheumatic Diseases in Patients Attending the University Hospital in Kinshasa. Clinical Rheumatology, 27, 47-54. https://doi.org/10.1007/s10067-007-0650-x
|
[17]
|
Ndongo, S., Lekpa, F.K., Ka, M.M., Ndiaye, N. and Diop, T.M. (2009) Presentation and Severity of Rheumatoid Arthritis at Diagnosis in Senegal. Rheumatology (Oxford), 48, 1111-1113. https://doi.org/10.1093/rheumatology/kep178
|
[18]
|
Singwe-Ngandeu, M., Finckh, A., Bas, S., Tiercy, J.M. and Gabay, C. (2010) Diagnostic Value of Anti-Cyclic Citrullinated Peptides and Association with HLA-DRB1 Shared Epitope Alleles in African Rheumatoid Arthritis Patients. Arthritis Research & Therapy, 12, R36. https://doi.org/10.1186/ar2945
|
[19]
|
MacGregor, A.J., Riste, L.K., Hazes, J.M. and Silman, A.J. (1994) Low Prevalence of Rheumatoid Arthritis in Black-Caribbeans Compared with Whites in Inner City Manchester. Annals of Rheumatic Diseases, 53, 293-297. https://doi.org/10.1136/ard.53.5.293
|
[20]
|
Houzou, P., Oniankitan, O., Kakpovi, K., Koffi-Tessio, V.E., Tagbor, K.C., Fianyo, E., et al. (2013) Rheumatic Diseases Profile of 13517 West African Patients. La Tunisie Médicale, 91, 16-20.
|
[21]
|
Usenbo, A., Kramer, V., Young, T. and Musekiwa, A. (2015) Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis. PLOS ONE, 10, e0133858. https://doi.org/10.1371/journal.pone.0133858
|
[22]
|
Adelowo, O.O., Ojo, O., Oduenyi, I. and Okwara, C.C. (2010) Rheumatoid Arthritis among Nigerians: The First 200 Patients from a Rheumatology Clinic. Clinical Rheumatology, 29, 593-597. https://doi.org/10.1007/s10067-009-1355-0
|
[23]
|
Holoshitz, J. (2010) The Rheumatoid Arthritis HLA-DRB1 Shared Epitope. Current Opinion in Rheumatology, 22, 293-298. https://doi.org/10.1097/BOR.0b013e328336ba63
|
[24]
|
MacGregor, A.J., Snieder, H., Rigby, A.S., Koskenvuo, M., Kaprio, J., Aho, K., et al. (2000) Characterizing the Quantitative Genetic Contribution to Rheumatoid Arthritis Using Data from Twins. Arthritis & Rheumatology, 43, 30-37. https://doi.org/10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B
|
[25]
|
Berglin, E., Padyukov, L., Sundin, U., Hallmans, G., Stenlund, H., Van Venrooij, W.J., et al. (2004) A Combination of Autoantibodies to Cyclic Citrullinated Peptide (CCP) and HLA-DRB1 Locus Antigens Is Strongly Associated with Future Onset of Rheumatoid Arthritis. Arthritis Research & Therapy, 6, R303-R308. https://doi.org/10.1186/ar1187
|
[26]
|
Kazkaz, L., Marotte, H., Hamwi, M., Angelique Cazalis, M., Roy, P., Mougin, B., et al. (2007) Rheumatoid Arthritis and Genetic Markers in Syrian and French Populations: Different Effect of the Shared Epitope. Annals of Rheumatic Diseases, 66, 195-201. https://doi.org/10.1136/ard.2004.033829
|
[27]
|
van Gaalen, F.A., van Aken, J., Huizinga, T.W., Schreuder, G.M., Breedveld, F.C., Zanelli, E., et al. (2004) Association between HLA Class II Genes and Autoantibodies to Cyclic Citrullinated Peptides (CCPs) Influences the Severity of Rheumatoid Arthritis. Arthritis & Rheumatology, 50, 2113-2121. https://doi.org/10.1002/art.20316
|
[28]
|
Silman, A.J. and Pearson, J.E. (2002) Epidemiology and Genetics of Rheumatoid Arthritis. Arthritis Research, 4, S265-272. https://doi.org/10.1186/ar578
|
[29]
|
Thomson, W., Harrison, B., Ollier, B., Wiles, N., Payton, T., Barrett, J., et al. (1999) Quantifying the Exact Role of HLA-DRB1 Alleles in Susceptibility to Inflammatory Polyarthritis: Results from a Large, Population-Based Study. Arthritis & Rheumatology, 42, 757-762. https://doi.org/10.1002/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X
|
[30]
|
Kochi, Y., Suzuki, A., Yamada, R. and Yamamoto, K. (2009) Genetics of Rheumatoid Arthritis: Underlying Evidence of Ethnic Differences. Journal of Autoimmunity, 32, 158-162. https://doi.org/10.1016/j.jaut.2009.02.020
|
[31]
|
Charpin, C., Balandraud, N., Guis, S., Roudier, C., Toussirot, E., Rak, J., et al. (2008) HLA-DRB1*0404 Is Strongly Associated with High Titers of Anti-Cyclic Citrullinated Peptide Antibodies in Rheumatoid Arthritis. Clinical and Experimental Rheumatology, 26, 627-631.
|
[32]
|
Malemba, J.J., Mbuyi-Muamba, J.M., Mukaya, J., Bossuyt, X., Emonds, M.P., Deiteren, K., et al. (2013) The Phenotype and Genotype of Rheumatoid Arthritis in the Democratic Republic of Congo. Arthritis Research & Therapy, 15, R89. https://doi.org/10.1186/ar4269
|
[33]
|
Gonzalez-Gay, M.A., Garcia-Porrua, C. and Hajeer, A.H. (2002) Influence of Human Leukocyte Antigen-DRB1 on the Susceptibility and Severity of Rheumatoid Arthritis. Seminars in Arthritis and Rheumatism, 31, 355-360. https://doi.org/10.1053/sarh.2002.32552
|
[34]
|
Pascual, M., Nieto, A., Lopez-Nevot, M.A., Ramal, L., Mataran, L., Caballero, A., et al. (2001) Rheumatoid Arthritis in Southern Spain: Toward Elucidation of a Unifying Role of the HLA Class II Region in Disease Predisposition. Arthritis & Rheumatology, 44, 307-314. https://doi.org/10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K
|
[35]
|
Hughes, L.B., Morrison, D., Kelley, J.M., Padilla, M.A., Vaughan, L.K., Westfall, A.O., et al. (2008) The HLA-DRB1 Shared Epitope Is Associated with Susceptibility to Rheumatoid Arthritis in African Americans through European Genetic Admixture. Arthritis & Rheumatology, 58, 349-358. https://doi.org/10.1002/art.23166
|
[36]
|
Chun-Lai, T., Padyukov, L., Dhaliwal, J.S., Lundstrom, E., Yahya, A., Muhamad, N.A., et al. (2011) Shared Epitope Alleles Remain a Risk Factor for Anti-Citrullinated Proteins Antibody (ACPA)-Positive Rheumatoid Arthritis in Three Asian Ethnic Groups. PLOS ONE, 6, e21069. https://doi.org/10.1371/journal.pone.0021069
|
[37]
|
Liu, S.C., Chang, T.Y., Lee, Y.J., Chu, C.C., Lin, M., Chen, Z.X., et al. (2007) Influence of HLA-DRB1 Genes and the Shared Epitope on Genetic Susceptibility to Rheumatoid Arthritis in Taiwanese. The Journal of Rheumatology, 34, 674-680.
|
[38]
|
Meyer, P.W., Hodkinson, B., Ally, M., Musenge, E., Wadee, A.A., Fickl, H., et al. (2011) HLA-DRB1 Shared Epitope Genotyping Using the Revised Classification and Its Association with Circulating Autoantibodies, Acute Phase Reactants, Cytokines and Clinical Indices of Disease Activity in a Cohort of South African Rheumatoid Arthritis Patients. Arthritis Research & Therapy, 13, R160. https://doi.org/10.1186/ar3479
|
[39]
|
Malemba, J.J., Mbuyi-Muamba, J.M., Mukaya, J., Bossuyt, X., Verschueren, P. and Westhovens, R. (2012) The Epidemiology of Rheumatoid Arthritis in Kinshasa, Democratic Republic of Congo—A Population-Based Study. Rheumatology (Oxford), 51, 1644-1647. https://doi.org/10.1093/rheumatology/kes092
|
[40]
|
McGill, P. (1991) Rheumatoid Arthritis in Sub-Saharan Africa. Annals of Rheumatic Diseases, 50, 965-966. https://doi.org/10.1136/ard.50.12.965
|
[41]
|
Ndongo, S., Pouye, A., Lekpa, F.K., Bihehe, D.M., Tiendrebeogo, J., Ndao, A.C., et al. (2012) Disease-Modifying Treatment for Inflammatory Rheumatism in Sub-Saharan Africa: Outcome at 6 Months of 205 Senegalese Patients with Rheumatoid Arthritis. Médecine et Santé Tropicales, 22, 385-389. https://doi.org/10.1684/mst.2012.0096
|
[42]
|
Hodkinson, B., Meyer, P.W., Musenge, E., Ally, M.M., Wadee, A.A. anderson, R., et al. (2010) The Diagnostic Utility of the Anti-CCP Antibody Test Is No Better than Rheumatoid Factor in South Africans with Early Rheumatoid Arthritis. Clinical Rheumatology, 29, 615-618. https://doi.org/10.1007/s10067-010-1374-x
|
[43]
|
Ouedraogo, D.D., Singbo, J., Diallo, O., Sawadogo, S.A., Tieno, H. and Drabo, Y.J. (2011) Rheumatoid Arthritis in Burkina Faso: Clinical and Serological Profiles. Clinical Rheumatology, 30, 1617-1621. https://doi.org/10.1007/s10067-011-1831-1
|
[44]
|
Greenberg, J.D., Spruill, T.M., Shan, Y., Reed, G., Kremer, J.M., Potter, J., et al. (2013) Racial and Ethnic Disparities in Disease Activity in Patients with Rheumatoid Arthritis. The American Journal of Medicine, 126, 1089-1098. https://doi.org/10.1016/j.amjmed.2013.09.002
|
[45]
|
Silman, A.J., Newman, J. and MacGregor, A.J. (1996) Cigarette Smoking Increases the Risk of Rheumatoid Arthritis. Results from a Nationwide Study of Disease-Discordant Twins. Arthritis & Rheumatology, 39, 732-735. https://doi.org/10.1002/art.1780390504
|
[46]
|
Anderson, R., Meyer, P.W., Ally, M.M. and Tikly, M. (2016) Smoking and Air Pollution as Pro-Inflammatory Triggers for the Development of Rheumatoid Arthritis. Nicotine & Tobacco Research, 18, 1556-1565. https://doi.org/10.1093/ntr/ntw030
|
[47]
|
Mikuls, T.R., Hughes, L.B., Westfall, A.O., Holers, V.M., Parrish, L., van der Heijde, D., et al. (2008) Cigarette Smoking, Disease Severity and Autoantibody Expression in African Americans with Recent-Onset Rheumatoid Arthritis. Annals of Rheumatic Diseases, 67, 1529-1534. https://doi.org/10.1136/ard.2007.082669
|
[48]
|
Meyer, P., Ally, M., Hodkinson, B. anderson, R. and Tikly, M. (2018) Diagnostic Utility of, and Influence of Tobacco Usage and Genetic Predisposition on, Immunoglobulin A, Rheumatoid Factor and Anti-Citrullinated Peptide Auto-Antibodies in South African Rheumatoid Arthritis Patients. African Health Sciences, 18, 295-303. https://doi.org/10.4314/ahs.v18i2.14
|
[49]
|
Mody, G.M. (1995) Rheumatoid Arthritis and Connective Tissue Disorders: Sub-Saharan Africa. Baillière’s Clinical Rheumatology, 9, 31-44. https://doi.org/10.1016/S0950-3579(05)80141-4
|
[50]
|
Hodkinson, B., Tikly, M. and Adebajo, A. (2014) Rheumatoid Arthritis in the Developing World: Stepping Up to the Challenge. Clinical Rheumatology, 33, 1195-1196. https://doi.org/10.1007/s10067-014-2690-3
|
[51]
|
Symmons, D.P. and Chakravarty, K. (1993) Can Immunisation Trigger Rheumatoid Arthritis? Annals of Rheumatic Diseases, 52, 843-844. https://doi.org/10.1136/ard.52.12.843
|
[52]
|
Greenwood, B.M. (1968) Autoimmune Disease and Parasitic Infections in Nigerians. The Lancet, 17, 380-382. https://doi.org/10.1016/S0140-6736(68)90595-3
|
[53]
|
Greenwood, B.M., Herrick, E.M. and Voller A. (1970) Can Parasitic Infection Suppress Autoimmune Disease? Proceedings of the Royal Society of Medicine, 63, 19-20. https://doi.org/10.1177/003591577006300107
|
[54]
|
Matisz, C.E., McDougall, J.J., Sharkey, K.A. and McKay, D.M. (2011) Helminth Parasites and the Modulation of Joint Inflammation. Journal of Parasitology Research, 2011, Article ID: 942616. https://doi.org/10.1155/2011/942616
|
[55]
|
Pineda, M.A., Al-Riyami, L., Harnett, W. and Harnett, M.M. (2014) Lessons from Helminth Infections: ES-62 Highlights New Interventional Approaches in Rheumatoid Arthritis. Clinical and Experimental Immunology, 177, 13-23. https://doi.org/10.1111/cei.12252
|
[56]
|
Rodgers, D.T., Pineda, M.A., McGrath, M.A., Al-Riyami, L., Harnett, W. and Harnett, M.M. (2014) Protection against Collagen-Induced Arthritis in Mice Afforded by the Parasitic Worm Product, ES-62, Is Associated with Restoration of the Levels of Interleukin-10-Producing B Cells and Reduced Plasma Cell Infiltration of the Joints. Immunology, 141, 457-466. https://doi.org/10.1111/imm.12208
|
[57]
|
Song, X., Shen, J., Wen, H., Zhong, Z., Luo, Q., Chu, D., et al. (2011) Impact of Schistosoma japonicum Infection on Collagen-Induced Arthritis in DBA/1 Mice: A Murine Model of Human Rheumatoid Arthritis. PLOS ONE, 6, e23453. https://doi.org/10.1371/journal.pone.0023453
|
[58]
|
Greenwood, B.M., Herrick, E.M. and Voller, A. (1970) Suppression of Autoimmune Disease in NZB and (NZB x NZW) F1 Hybrid Mice by Infection with Malaria. Nature, 226, 266-267. https://doi.org/10.1038/226266a0
|
[59]
|
Hyrich, K.L. and Inman, R.D. (2001) Infectious Agents in Chronic Rheumatic Diseases. Current Opinion in Rheumatology, 13, 300-304. https://doi.org/10.1097/00002281-200107000-00010
|
[60]
|
Liao, K.P., Alfredsson, L. and Karlson, E.W. (2009) Environmental Influences on Risk for Rheumatoid Arthritis. Current Opinion in Rheumatology, 21, 279-283. https://doi.org/10.1097/BOR.0b013e32832a2e16
|
[61]
|
Malemba, J.J., Mbuyi Muamba, J.M., Mukaya, J., Bossuyt, X., Verschueren, P. and Westhovens, R. (2013) Treatment of Rheumatoid Arthritis with Methotrexate in Congolese Patients. Clinical Rheumatology, 32, 1323-1327. https://doi.org/10.1007/s10067-013-2269-4
|
[62]
|
Lukas, C., Guillemin, F., Landewe, R., van der Heijde, D., Logeart, I., Fautrel, B., et al. (2009) Factors Determining a DMARD Initiation in Early Inflammatory Arthritis Patients. The ESPOIR Cohort Study. Clinical and Experimental Rheumatology, 27, 84-91.
|
[63]
|
Lekpa, F.K., Ndongo, S., Tiendrebeogo, J., Ndao, A.C., Daher, A., Pouye, A., et al. (2012) Rheumatoid Arthritis in Senegal: A Comparison between Patients Coming from Rural and Urban Areas, in an Urban Tertiary Health Care Center in Senegal. Clinical Rheumatology, 31, 1617-1620. https://doi.org/10.1007/s10067-012-2054-9
|
[64]
|
Meune, C., Touze, E., Trinquart, L. and Allanore, Y. (2009) Trends in Cardiovascular Mortality in Patients with Rheumatoid Arthritis over 50 Years: A Systematic Review and Meta-Analysis of Cohort Studies. Rheumatology (Oxford), 48, 1309-1313. https://doi.org/10.1093/rheumatology/kep252
|
[65]
|
Dodo-Siddo, M.N., Diao, M., Ndiaye, M.B., Ndongo, S., Kane, A., Mbaye, A., et al. (2016) Study of Echocardiographic Parameters of Rheumatoid Arthritis Black African without Clinically Evident Cardiovascular Manifestations: A Cross-Sectional Study of 73 Cases in Senegal. Annales de Cardiologie et d’Angéiologie (Paris), 65, 71-76. https://doi.org/10.1016/j.ancard.2015.01.015
|
[66]
|
Lukas, C., Combe, B., Ravaud, P., Sibilia, J., Landew, R. and van der Heijde D. (2011) Favorable Effect of Very Early Disease-Modifying Antirheumatic Drug Treatment on Radiographic Progression in Early Inflammatory Arthritis: Data from the Etude et Suivi des polyarthrites indifferenciees recentes (Study and Follow-Up of Early Undifferentiated Polyarthritis). Arthritis & Rheumatology, 63, 1804-1811. https://doi.org/10.1002/art.30371
|
[67]
|
Ka, M.M., Diallo, S., Ka, E.F., Diop, B.M., Pouye, A., Mbengue, M., et al. (2000) Treatment of Rheumatoid Polyarthritis with Methotrexate in Dakar: Efficacy, Tolerance and Cost. Sante, 10, 65-68.
|
[68]
|
Ravindran, V., Seah, M.A., Elias, D.A., Choy, E.H., Scott, D.L. and Gordon, P.A. (2008) Clinical and Radiological Features of Rheumatoid Arthritis in British Black Africans. Clinical Rheumatology, 27, 97-100. https://doi.org/10.1007/s10067-007-0735-6
|
[69]
|
Greenwood, B.M. and Herrick, E.M. (1970) Low Incidence of Rheumatoid Factor and Autoantibodies in Nigerian Patients with Rheumatoid Arthritis. British Medical Journal, 1, 71-73. https://doi.org/10.1136/bmj.1.5688.71
|
[70]
|
Farid, S., Azizi, G. and Mirshafiey, A. (2013) Anti-Citrullinated Protein Antibodies and Their Clinical Utility in Rheumatoid Arthritis. International Journal of Rheumatic Diseases, 16, 379-386. https://doi.org/10.1111/1756-185X.12129
|
[71]
|
Steiner, G. and Smolen, J. (2002) Autoantibodies in Rheumatoid Arthritis and Their Clinical Significance. Arthritis Research, 4, S1-S5. https://doi.org/10.1186/ar551
|
[72]
|
Davis, P., Stein, M., Ley, H. and Johnston, C. (1989) Serological Profiles in the Connective Tissue Diseases in Zimbabwean Patients. Annals of Rheumatic Diseases, 48, 73-76. https://doi.org/10.1136/ard.48.1.73
|
[73]
|
Pruijn, G.J., Wiik, A. and van Venrooij, W.J. (2010) The Use of Citrullinated Peptides and Proteins for the Diagnosis of Rheumatoid Arthritis. Arthritis Research & Therapy, 12, 203. https://doi.org/10.1186/ar2903
|
[74]
|
Dubrous, P., Gardet, V. and Hugard, L. (2005) Value of Anti-Cyclic Citrullinated Peptides Antibodies in Comparison with Rheumatoid Factor for Rheumatoid Arthritis Diagnosis. Pathologie Biologie (Paris), 53, 63-67. https://doi.org/10.1016/j.patbio.2004.04.019
|
[75]
|
Kroot, E.J., de Jong, B.A., van Leeuwen, M.A., Swinkels, H., van den Hoogen, F.H., van’t Hof, M., et al. (2000) The Prognostic Value of Anti-Cyclic Citrullinated Peptide Antibody in Patients with Recent-Onset Rheumatoid Arthritis. Arthritis & Rheumatology, 43, 1831-1835. https://doi.org/10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6
|
[76]
|
Machold, K.P., Stamm, T.A., Nell, V.P., Pflugbeil, S., Aletaha, D., Steiner, G., et al. (2007) Very Recent Onset Rheumatoid Arthritis: Clinical and Serological Patient Characteristics Associated with Radiographic Progression over the First Years of Disease. Rheumatology (Oxford), 46, 342-349. https://doi.org/10.1093/rheumatology/kel237
|
[77]
|
van der Helm-van Mil, A.H., Verpoort, K.N., Breedveld, F.C., Toes, R.E. and Huizinga, T.W. (2005) Antibodies to Citrullinated Proteins and Differences in Clinical Progression of Rheumatoid Arthritis. Arthritis Research & Therapy, 7, R949-R958. https://doi.org/10.1186/ar1767
|
[78]
|
Diaz-Toscano, M.L., Olivas-Flores, E.M., Zavaleta-Muniz, S.A., Gamez-Nava, J.I., Cardona-Munoz, E.G., Ponce-Guarneros, M., et al. (2014) Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in Relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing. BioMed Research International, 2014, Article ID: 198198. https://doi.org/10.1155/2014/198198
|
[79]
|
Yousefghahari, B., Alhooei, S., Soleimani-Amiri, M.J. and Guran, A. (2013) Comparison of Sensitivity and Specificity of Anti-CCP and Anti-MCV Antibodies in an Iranian Cohort of Patients with Rheumatoid Arthritis. Caspian Journal of Internal Medicine, 4, 702-706.
|
[80]
|
Dejaco, C., Klotz, W., Larcher, H., Duftner, C., Schirmer, M. and Herold, M. (2006) Diagnostic Value of Antibodies against a Modified Citrullinated Vimentin in Rheumatoid Arthritis. Arthritis Research & Therapy, 8, R119. https://doi.org/10.1186/ar2008
|
[81]
|
Sghiri, R., Bouajina, E., Bargaoui, D., Harzallah, L., Fredj, H.B., Sammoud, S., et al. (2008) Value of Anti-Mutated Citrullinated Vimentin Antibodies in Diagnosing Rheumatoid Arthritis. Rheumatology International, 29, 59-62. https://doi.org/10.1007/s00296-008-0614-8
|
[82]
|
Wagner, E., Skoumal, M., Bayer, P.M. and Klaushofer, K. (2009) Antibody against Mutated Citrullinated Vimentin: A New Sensitive Marker in the Diagnosis of Rheumatoid Arthritis. Rheumatology International, 29, 1315-1321. https://doi.org/10.1007/s00296-009-0854-2
|
[83]
|
Bartoloni, E., Alunno, A., Bistoni, O., Bizzaro, N., Migliorini, P., Morozzi, G., et al. (2012) Diagnostic Value of Anti-Mutated Citrullinated Vimentin in Comparison to Anti-Cyclic Citrullinated Peptide and Anti-Viral Citrullinated Peptide 2 Antibodies in Rheumatoid Arthritis: An Italian Multicentric Study and Review of the Literature. Autoimmunity Reviews, 11, 815-820. https://doi.org/10.1016/j.autrev.2012.02.015
|
[84]
|
Meric de Bellefon, L., Epee, H., Langhendries, J.P., De Wit, S., Corazza, F. and Di Romana, S. (2015) Increase in the Prevalence of Anti-Cyclic Citrullinated Peptide Antibodies in the Serum of 185 Patients Infected with Human Immunodeficiency Virus. Joint Bone Spine, 82, 467-468. https://doi.org/10.1016/j.jbspin.2015.08.014
|
[85]
|
Damjanovska, L., Thabet, M.M., Levarth, E.W., Stoeken-Rijsbergen, G., van der Voort, E.I., Toes, R.E., et al. (2010) Diagnostic Value of Anti-MCV Antibodies in Differentiating Early Inflammatory Arthritis. Annals of Rheumatic Diseases, 69, 730-732. https://doi.org/10.1136/ard.2009.108456
|
[86]
|
Vander Cruyssen, B., Nogueira, L., Van Praet, J., Deforce, D., Elewaut, D., Serre, G., et al. (2008) Do All Anti-Citrullinated Protein/Peptide Antibody Tests Measure the Same? Evaluation of Discrepancy between Anti-Citrullinated Protein/Peptide Antibody Tests in Patients with and without Rheumatoid Arthritis. Annals of Rheumatic Diseases, 67, 542-546. https://doi.org/10.1136/ard.2007.071654
|
[87]
|
Mutlu, N., Bicakcigil, M., Tasan, D.A., Kaya, A., Yavuz, S. and Ozden, A.I. (2009) Comparative Performance Analysis of 4 Different Anti-Citrullinated Protein Assays in the Diagnosis of Rheumatoid Arthritis. The Journal of Rheumatology, 36, 491-500. https://doi.org/10.3899/jrheum.080656
|
[88]
|
Buch, M.H. and Emery, P. (2011) New Therapies in the Management of Rheumatoid Arthritis. Current Opinion in Rheumatology, 23, 245-251. https://doi.org/10.1097/BOR.0b013e3283454124
|
[89]
|
Conti, F., Ceccarelli, F., Massaro, L., Cipriano, E., Di Franco, M., Alessandri, C., et al. (2013) Biological Therapies in Rheumatic Diseases. Clinical Therapeutics, 164, e413-e428.
|
[90]
|
Adelowo, O.O., Olisa, O., Asekhame, O.T. and Ojo, O. (2021) Biotherapies in Medical Practice: A Review and the Nigerian Experience. West African Journal of Medicine, 38, 486-493.
|
[91]
|
Carter, R.M.N., Jansen van Rensburg, B.J. and Joubert, G. (2019) Control of Rheumatoid Arthritis with Conventional Disease-Modifying Antirheumatic Drugs in a Tertiary Hospital in Central South Africa. South African Medical Journal, 110, 27-31. https://doi.org/10.7196/SAMJ.2019.v110i1.14099
|
[92]
|
Mody, G.M. (2017) Rheumatology in Africa—Challenges and Opportunities. Arthritis Research & Therapy, 19, 49. https://doi.org/10.1186/s13075-017-1259-3
|
[93]
|
Yerima, A., Akintayo, R. and Adebajo, A. (2022) Implications of a Diagnosis of Rheumatoid Arthritis in Resource-Poor Countries. Best Practice & Research: Clinical Rheumatology, 36, Article ID: 101725. https://doi.org/10.1016/j.berh.2021.101725
|
[94]
|
Bester, F.C., Bosch, F.J. and van Rensburg B.J. (2016) The Specialist Physician’s Approach to Rheumatoid Arthritis in South Africa. The Korean Journal of Internal Medicine, 31, 219-236. https://doi.org/10.3904/kjim.2015.134
|
[95]
|
Kolou, M., Bigot, A., Kakpovi, K., Amenyah-Ehlan, A., Salou, M., Mijiyawa, M., et al. (2017) Access to Immunological Markers for the Management of Rheumatoid Arthritis in Togo with Regard to 2010 ACR/EULAR Classification. MOJ Immunology, 6, Article No. 00180. https://doi.org/10.15406/moji.2017.05.00180
|